A molecular diagnostic test kit for HPV screening recommended by the CNR Papillomavirus for cervical cancer detection. The test has been validated through rigorous clinical studies demonstrating sensitivity, specificity, and compliance with international standards.
Manufactured by
APPOLON BIOTECK SAS
Chaponnay, France
This French company specializes in molecular biology applied to medical diagnostics, developing, manufacturing and marketing in vitro diagnostic devices. The company focuses on infectious diseases, oncology and human genetics, providing modular solutions for laboratories ranging from emergency services to medical biology platforms. Based in the Lyon region, the company operates with ISO 13485:2016 certification and employs over 40 staff members including 20 molecular biology researchers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 1 relevant product
shanghai rendu biotechnology co.,ltd.
China · 2 relevant products
52 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 115 closest product alternatives
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for detecting and genotyping high-risk human papillomavirus strains. Supports cervical cancer screening and risk stratification.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A point-of-care testing assay that detects and differentiates high-risk HPV subtypes. Enables rapid screening for cervical cancer risk at the point of care.
shanghai rendu biotechnology co.,ltd. · China
AmpSure® HPV Assay is an in vitro diagnostic test for the detection and identification of human papillomavirus RNA in clinical specimens. The assay leverages advanced RNA detection technology to deliver precise results for cervical cancer screening and HPV-related disease management. Designed for clinical laboratory use with optimized sensitivity and specificity.
112 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products